4//SEC Filing
Pavliv Leo 4
Accession 0001209191-22-040113
CIK 0001087294other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 3:13 PM ET
Size
9.2 KB
Accession
0001209191-22-040113
Insider Transaction Report
Form 4
Pavliv Leo
Vice President, Operations
Transactions
- Other
Common Stock
2022-05-31$2.09/sh−33,500$70,015→ 129,618 total - Disposition to Issuer
Options (right to buy)
2022-03-16−5,000→ 0 totalExercise: $2.59From: 2026-03-16Exp: 2032-03-16→ Common Stock (5,000 underlying) - Disposition to Issuer
Options (right to buy)
2021-03-17−5,000→ 0 totalExercise: $3.22From: 2025-03-17Exp: 2031-03-17→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]Retired from position as Executive Vice President, Chief Development & Operations Officer on May 31, 2022. All unvested equity awards forfeited upon retirement.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001408593
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 3:13 PM ET
- Size
- 9.2 KB